Melissa Tam
Family · New York, NYNPI 1891178919
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,998 of the $16,298 with a category attached, or 73.6%. 27 manufacturers reported payments, led by Esperion Therapeutics, Inc. at 24.3% of the total. Reporting peaked in 2021 at $6,307 and has fallen 65.1% since, to $2,199 in 2025. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $107.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$4K
- AbbVie$3K
- AstraZeneca$1K
- Biohaven Pharmaceuticals, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$995
- Novo Nordisk$965
- plus $5K from 21 others
What the payments were for
- Consulting fees$8005%
- Speaking & faculty fees$3,50021%
- Food & beverage$11,99874%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 13 | $3,967 |
| AbbVie | 31 | $2,797 |
| AstraZeneca | 10 | $1,207 |
| Biohaven Pharmaceuticals, Inc. | 3 | $1,033 |
| Teva Pharmaceuticals USA, Inc. | 8 | $995 |
| Novo Nordisk | 8 | $965 |
| Boehringer Ingelheim | 6 | $738 |
| Axsome Therapeutics, Inc. | 4 | $522 |
| Lilly USA, LLC | 4 | $476 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $465 |
| Johnson & Johnson | 4 | $426 |
| Amgen(2 entities) | 4 | $381 |
| GSK | 3 | $372 |
| Intra-sana Laboratories | 3 | $228 |
| Boston Scientific | 8 | $211 |
| Averitas Pharma Inc. | 1 | $154 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Genentech USA, Inc. | 1 | $150 |
| Urovant Sciences Inc | 1 | $149 |
| Neos Therapeutics, LP | 12 | $140 |
| Seagen Inc. | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $124 |
| Bayer | 1 | $122 |
| Abbott | 1 | $121 |
| Amarin Pharma, Inc. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,298 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.